These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 17030191)

  • 1. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
    Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
    Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
    Kwan HT; Chan DW; Cai PC; Mak CS; Yung MM; Leung TH; Wong OG; Cheung AN; Ngan HY
    PLoS One; 2013; 8(1):e53597. PubMed ID: 23301094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
    Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
    Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.
    Angers S; Thorpe CJ; Biechele TL; Goldenberg SJ; Zheng N; MacCoss MJ; Moon RT
    Nat Cell Biol; 2006 Apr; 8(4):348-57. PubMed ID: 16547521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
    Prasad CP; Gupta SD; Rath G; Ralhan R
    Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases.
    Bernatik O; Ganji RS; Dijksterhuis JP; Konik P; Cervenka I; Polonio T; Krejci P; Schulte G; Bryja V
    J Biol Chem; 2011 Mar; 286(12):10396-410. PubMed ID: 21285348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of endocytosis blocks Wnt signalling to beta-catenin by promoting dishevelled degradation.
    Bryja V; Cajánek L; Grahn A; Schulte G
    Acta Physiol (Oxf); 2007 May; 190(1):55-61. PubMed ID: 17428233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein.
    Funato Y; Terabayashi T; Sakamoto R; Okuzaki D; Ichise H; Nojima H; Yoshida N; Miki H
    Curr Biol; 2010 Nov; 20(21):1945-52. PubMed ID: 20970343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines.
    Çalışkan C; Pehlivan M; Yüce Z; Sercan O
    Mol Biol Rep; 2017 Oct; 44(5):391-397. PubMed ID: 28840581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
    Uematsu K; Kanazawa S; You L; He B; Xu Z; Li K; Peterlin BM; McCormick F; Jablons DM
    Cancer Res; 2003 Aug; 63(15):4547-51. PubMed ID: 12907630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
    Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
    Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells.
    Esufali S; Charames GS; Pethe VV; Buongiorno P; Bapat B
    Cancer Res; 2007 Mar; 67(6):2469-79. PubMed ID: 17363564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma.
    Nambotin SB; Wands JR; Kim M
    Anticancer Agents Med Chem; 2011 Jul; 11(6):549-59. PubMed ID: 21554202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.